Clinical effects of transobturator tape procedure with porcine small intestine submucosa for female stress urinary incontinence  by Wang, Chiu-Lin et al.
Kaohsiung Journal of Medical Sciences (2016) 32, 142e146Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.kjms-onl ine.comORIGINAL ARTICLEClinical effects of transobturator tape procedure
with porcine small intestine submucosa for
female stress urinary incontinence
Chiu-Lin Wang a, Ching-Ju Shen b, Kun-Ling Lin b, Cheng-Yu Long a,c,*a Department of Obstetrics and Gynecology, Kaohsiung Municipal Hsiao-Kang Hospital,
Kaohsiung Medical University, Kaohsiung, Taiwan
b Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital,
Kaohsiung, Taiwan
c Department of Obstetrics and Gynecology, Graduate Institute of Medicine, College of
Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanReceived 9 November 2015; accepted 1 February 2016
Available online 7 April 2016KEYWORDS
Biologic graft;
Graft-versus-host
disease;
Small intestine
submucosa;
Stress urinary
incontinence;
Transobturator tapeConflicts of interest: All authors d
* Corresponding author. Department
Kang Dist. 812, Kaohsiung, Taiwan.
E-mail address: urolong@yahoo.co
http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2016, Kaohsiu
BY-NC-ND license (http://creativecomAbstract The aim of this study was to evaluate the efficacy of the transobturator tape (TOT)
procedure using porcine small intestine submucosa (SIS) for the treatment of female stress uri-
nary incontinence (SUI). Forty-two consecutive patients with SUI who underwent the TOT pro-
cedure with porcine SIS were enrolled. The surgical outcomes, and data of urodynamic study
and a questionnaire prior to and after surgery were collected and analyzed retrospectively. SUI
was reported subjectively cured in 34 of the 42 patients (81.0%) 1 year after surgery, and
declined to the rate of 66.7% at 5 years postoperatively. The subjective symptoms of frequency
and nocturia also improved significantly (p < 0.01). Graft-versus-host disease (GVHD) devel-
oped in four patients, but without major complications. Despite the bladder volume at first
desire to void increased significantly after surgery (p < 0.01), the remaining urodynamic pa-
rameters did not differ in a significant manner. In conclusion, the long-term cure rate of the
TOT procedure with SIS is lower than with synthetic materials, but with relatively lower
morbidity.
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Figure 1. Transobturator tape (TOT) procedure with small
intestine submucosa (SIS), the position of the mesh placed, and
the incision wounds.
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Stress urinary incontinence (SUI), affecting approximately
4% to 35% of women [1,2], is a common disorder which can
greatly impact the quality of life of affected individuals.
Management of SUI includes conservative and surgical
treatments. Over 100 types of anti-incontinence surgeries
were invented since the introduction of Kelly’s plication in
1915 [3]. Different kinds of surgical approach were devel-
oped, including abdominal, vaginal, laparoscopic, and
combined procedures. In the past 2 decades, minimally
invasive midurethral slings have become the procedure of
choice for female SUI, since its introduction in 1995 [4]. The
two main categories are tension-free vaginal tape (TVT)
and transobturator tape (TOT). TVT was introduced in 1995
with a high success rate [5], but it has been associated with
various complications, such as bladder perforation, urinary
retention, and vascular and bowel injuries [6,7]. TOT was
then introduced in 2001 [8] with the goal of avoiding some
of the complications of TVT.
Apart from the different approaches of midurethral
slings, four types of reconstructive materials differ by the
sources which are available, including allografts, auto-
grafts, synthetic grafts, and xenografts. Each graft has its
advantages and drawbacks, however limited data is avail-
able to determine which materials are superior to the
others.
Autografts are harvested from the patients themselves.
Host reaction seldom occurs with autografts, however, its
use is limited by its morbidity associated with harvesting,
such as longer operative time, causing greater post-
operative pain and a longer time for recovery [9]. Allografts
harvested from cadaveric human donors eliminate the
morbidity associated with autologous graft harvest. How-
ever, supply shortage is a main problem of allografts. Syn-
thetic grafts have the advantages of not requiring
harvesting and being cost-effective, but increased compli-
cations of infection and extrusion were noted. Allman et al.
[10] demonstrated implanted small intestine submucosa
(SIS) may induce a vigorous response of tissue acceptance
rather than rejection. As a result, xenografts were devel-
oped to lower these complications.
Stratasis TF (Cook Urological Incorporated, Spencer, IN,
USA) is derived from the extracellular matrix of porcine SIS.
It is an acellular, nonimmunogenic, xenogenic, and
collagen-based biomaterial. Studies concerning the efficacy
of porcine dermis (Pelvicol) with a pubovaginal approach
have been reported [6e8], but little information was ob-
tained about the porcine SIS with a midurethral tape
approach. The purpose of this paper was to evaluate the
efficacy, safety, and morbidity of porcine SIS used for TOT
surgery in women with SUI. To our knowledge, this is the
first study investigating the results of the TOT procedure
using porcine SIS for the treatment of SUI.
Material and methods
This retrospective study included 69 women who under-
went a TOT procedure with Stratasis TF for SUI between
July 2002 and July 2005, and who were diagnosed both
clinically and urodynamically. All women had provenurodynamic stress incontinence without detrusor over-
activity. Twenty-seven women were excluded from this
study due to the following reasons: (1) incomplete medical
records (n Z 18); and (2) loss of follow up (n Z 9). Data
pertaining to 42 women were therefore assessed for the
present study. Basic demographic data were obtained at
their first visits. In addition, all patients underwent physical
examination, urodynamic assessment, and an interview to
identify urinary symptoms using the standardized ques-
tionnaire taking into account the 2010 International
Continence Society definitions [1]. The diagnosis of over-
active bladder (OAB) was made when the patient answered
“somewhat” or more to any one of the three urge questions
in the OAB V8 questionnaire (Question 2. An uncomfortable
urge to urinate? Question 3. A sudden urge to urinate with
little or no warning? Question 7. An uncontrollable urge to
urinate?) [11], once we had excluded any obvious etiology.
The same assessments were repeated again 6 months after
surgery.
Urodynamic studies were performed using a six channel
urodynamic monitor (MMS UD2000; Medical Measurements
Systems, Enschede, The Netherlands) according to the
recommendations by the International Continence Society
[1]. The studies included spontaneous uroflowmetry, both
filling (at a rate of 50 mL/min with a 10F Foley catheter)
and voiding cystometry with infusion of normal saline at
room temperature, and urethral pressure profilometry. Any
uninhibited detrusor contraction during filling cystometry
was deemed positive for idiopathic detrusor overactivity.
Intrinsic sphincter deficiency was defined as Valsalva leak-
point pressure < 60 cmH2O during filling cystometry.
After inducing laryngeal mask general anesthesia, the
patient was placed in a standard lithotomy position, legs in
stirrups, and thighs in hyperflexion. A single dose of pro-
phylactic antibiotics with 1 g of cefazolin (Cefamezin;
Fujisawa, Tokyo, Japan) was given 30 minutes prior to the
operation. A midline vertical incision over the anterior
vaginal wall was made 1 cm below the urethral meatus. The
vaginal wall was then dissected laterally using Metzenbaum
scissors (Prima, Tuttlingen, Germany) to the undersurface
of the bilateral obturator foramens. Another incision was
made on the perineum 2 cm lateral to the clitoris on both
Table 1 Clinical background of all participants in this
study.
Stratasis TF (n Z 42)
Age (y) 50.1  9.5
Body mass index (kg/m2) 25.1  4.1
Parity 3.0  1.3
Menopause 7 (40.5)
HT 6 (14.3)
ISD 5 (11.9)
Procedures in this study
Anterior mesh repair 6 (14.3)
Anterior and posterior mesh repair 4 (9.5)
Vaginal hysterectomy 3 (7.1)
Follow up (mo) 61.3  16.4
Values are given as mean  standard deviation or n (%).
HT Z hormone therapy; ISD Z intrinsic sphincter deficiency.
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perineal incision into the obturator foramen and the
dissected vaginal tunnel. Stratasis TF, rehydrated in normal
saline solution for approximately 10 minutes, was attached
to the tip of the trocar. Then, the trocar was backed out,
bringing the mesh out of the perineal incision. The same
procedure was performed at the other side [12]. The ten-
sion of the tape was adjusted by placing the Metzenbaum
scissors between the tape and the midurethra to avoid over
tension on the urethra. The opening of the vaginal mucosa
was then closed with absorbable sutures continuously. No
antibiotics were given after the operation. Both of the
authors were involved in the operations.
The Foley catheter and the vaginal gauze-roll were
removed approximately 24 hours after the operation and
the residual urine was then checked. The patient may be
discharged if the residual urine is <50 mL and there are no
significant complications. Any complications during and
after the operation were recorded. Subjective cure of SIS
was defined as absence of an episode of SUI after the
operation. Any postoperative SUI episode was deemed a
failure. Postoperative follow up was at 1 month, 3 months,
6 months, and 12 months, and then annually beyond 1 year.
With ethics approval by the institutional review broad of
our hospital, the patients’ charts were reviewed to assess
the outcome of surgery and the results were analyzed. The
subjective urinary symptoms before and after surgery were
compared using McNemar’s test. The values of urodynamic
parameters before and after surgery were compared by the
Wilcoxon signed rank test. A p value < 0.05 was considered
statistically significant.
SIS is an acellular, nonimmunogenic, resorbable, and
collagen-based biomaterial. SIS graft induces a T-helper
type 2 humoral immune response rather than T-helper type
1 in synthetic grafts [10]. Moreover, porcine collagen has a
95% homology to human collagen. It acts as a scaffold and
induces local host tissue cells to infiltrate its substance and
replace it with a remodeled sling of neo-autologous tissue
[13]. As a result, the xenograft induces tissue acceptance
rather than rejection.
Xenografts were used for midurethral slings in order to
lower the incidences of extrusion and infectious compli-
cations with synthetic grafts. In this study, no mesh
extrusion was noted in our patients, supporting the above
suggestion. However, graft-versus-host reaction (GVHD)
developed in four of our patients. Ulceration and exuda-
tion developed in all of them and persisted after
debridement and the usage of antibiotics. GVHD was
diagnosed by the histological findings of the subepithelial
cleft and an apoptotic keratinocyte in the squamous
epithelium with lymphocyte infiltration (exocytosis) and
focal hydropic change (spongiosis) as in Grade 3 GVHD. For
these cases, prednisolone (Donison, China Chemicals,
Taipei city, Taiwan) was given for 1 month and a mainte-
nance dose of 30 mg/d for 1 more month. Finally, the
wound resolved gradually after a 2-month course of
treatment [14]. In addition, intense postoperative
inflammation had also been reported [15,16]. Therefore,
more studies were warranted to determine the long-term
safety and efficacy, especially the immune response of
host to the implanted mesh in patients with immune dis-
ease or any type of allergy.Results
A total of 42 women undergoing the TOT procedure with SIS
in our hospital were analyzed. None had undergone previ-
ous surgeries for SUI. Table 1 shows the clinical back-
grounds of all participants in this study. The mean age was
50.1 years and the mean body mass index was 25.1. Forty
percent of the patients (17/42) were menopausal with
mean parity of three. Ten of 42 women (23.8%) had pelvic
organ prolapse and anterior and/or posterior mesh repair
were performed together. Intrinsic sphincter deficiency was
noted in five patients (11.9%).
The SUI was reported subjectively cured in 34 of the 42
patients (81.0%) 1 year after surgery, and declined to a rate
of 66.7% at 5 years postoperatively (Table 2). The compli-
cations of surgery are shown in Table 2. No intraoperative
complication occurred during surgery. One patient (2.4%)
developed de novo OAB, and seven cases (26.7%) had
postoperative urinary tract infection. Throughout the
period of follow up, no instances of graft infection and
extrusion occurred, but we found four cases of GVHD [14].
Table 3 shows subjective urinary symptoms of urge in-
continence, incomplete bladder emptying, and urinary
hesitancy improved, but not statistically significantly,
6 months postoperatively. However, the rates of SUI, fre-
quency, and nocturia decreased significantly (p < 0.01).
When we evaluated the urodynamic parameters prior to
and 6 months after operation, only 28 women agreed to
complete postoperative urodynamic study. Despite the
bladder volume at first desire to void being increased
significantly after surgery (p < 0.01), the remaining vari-
ables of the urodynamic study did not differ in a significant
manner (Table 4).
Discussion
Studies suggest that cross-linked xenografts may be
degraded in an unpredictable fashion after 180 days
[17,18]. After the degradation of the xenograft, it is un-
clear whether eventual graft loss affects the structural
integrity of the repair. Most of the previous studies were
concerned about the efficacy of cross-linked xenograft with
Table 2 Operative results and complications.
Stratasis TF (n Z 42)
Subjective cure rates
1 y rate 34 (81.0)
5 y rate 28 (66.7)
Operative complications
Bladder perforation 0
Vaginal erosion 0
Postoperative de novo OAB 1 (2.4)
Postoperative de novo BOO 0
Postoperative UTI 7 (16.7)
GVHD 4 (9.5)
Values are given as n (%).
BOO Z bladder outlet obstruction; GVHD Z graft-versus-host
disease; OAB Z overactive bladder; UTI Z urinary tract
infection.
Table 3 Urinary symptoms prior to and 6 months after
surgery.
n Z 42
Symptoms Preoperation Postoperation pa
Urgency incontinence 12 (28.6) 7 (16.7) 0.063
Frequency 23 (54.8) 9 (21.4) <0.01
Nocturia 17 (40.5) 8 (19.1) <0.01
Incomplete bladder
emptying
11 (31.0) 7 (16.7) 0.48
Hesitancy 8 (15.6) 4 (9.5) 0.13
Values are given as n (%).
a All p values were calculated by McNemar’s test.
Table 4 Urodynamic study variables prior to and 6 months
after surgery.
n Z 28
Variables Preoperation Postoperation pa
Qmax (mL/s) 22 (11e36) 21 (14e31) 0.73
RU (mL) 12 (0e61) 10 (0e55) 0.66
Pdap (cm H2O) 32 (6e60) 29 (6e50) 0.26
V1st (mL) 114 (66e156) 161 (83e327) <0.01
MCC (mL) 338 (173e527) 334 (178e477) 0.80
FUL (mm) 28 (20e38) 29 (15e38) 0.54
MUCP (cm H2O) 92 (48e147) 79 (19e123) 0.09
Values are given as median (range).
FULZ functional urethral length; MCCZmaximum cystometric
capacity; MUCP Z maximum urethral closure pressure;
PdapZ detrusor pressure at peak flow; QmaxZ maximum flow
rate; RUZ residual urine; V1stZ bladder volume at first desire
to void.
a All p values were calculated by Wilcoxon signed rank test.
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[19] reported comparable cure rates with TVT (85% vs. 89%)
[11]. By conrast, Guerrero et al. [20] reported asignificantly lower cure rate than TVT (22% vs. 55%) [20]. In
our study, the subjective cure rate of xenografts is 81.0%,
which was comparable with the cure rate of transobturator
synthetic grafts (82.4%) as reported in our previous study
[21]. However, the 5-year cure rate of xenografts dropped
to 66.7%. This was lower than the 5-year cure rate of the
TOT procedure using synthetic mesh (range approx.
72e87.4%) [22e26]. This means that the midurethral sup-
port by SIS mesh may have decreased after it was degraded.
The subjective symptoms of frequency and nocturia
after operation were improved significantly (p < 0.01).
Lower rates of OAB symptoms after surgery are possibly
related to the postoperative significant increase in bladder
volume at first desire to void during the filling cystometry,
in accordance with our previous study using the TOT pro-
cedure with synthetic mesh [27]. Segal et al. [28] also re-
ported similar results in 2004. However, Hsiao et al. [29,30]
reported no significant differences of first desire to void
before and after TOT procedures, but significantly higher
than the TVT group.
Over 20% of the patients had concomitant anterior with/
without posterior mesh repair; these concomitant surgeries
may have a possible effect on bladder neck and urinary
symptoms [31]. This may be a limitation of our study,
although concomitant Pelvic organ prolapse (POP) and SUI
procedures avoid the morbidity, the cost, and the recovery
time needed for two separate procedures.
The results of this study showed that the TOT procedure
using SIS mesh is a safe procedure providing a relatively
lower rate of postoperative complications, such as urethral
obstruction, mesh extrusion, and infection. However,
increased immune and allergic responses were noted in our
study. In addition, the long-term cure rate was lower than
with synthetic grafts. De novo OAB developed in only one
woman, and she was satisfactory under treatment with an
anticholinergic drug.
Increased success rates and decreased morbidity should
be the goals of midurethral sling surgery. According to our
study, Stratasis TF is a safe mesh material in the manage-
ment of SUI, but the 5-year success rate is lower than with
synthetic mesh. Therefore, further and longer follow up is
necessary to determine whether the structural integrity
persists after graft degradation and the maintenance of
continence rate. Finally, great attention should be given to
patients with immune disease or any type of allergy to the
immune response of host to the implanted mesh and the
development of GVHD.Acknowledgments
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